http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16777773

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 329
issn 1071-3581
1532-6551
issueIdentifier 2
pageRange 319-329
publicationName Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
startingPage 319
bibliographicCitation Ananthasubramaniam K, Weiss R, McNutt B, Klauke B, Feaheny K, Bukofzer S. A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease. Journal of Nuclear Cardiology. 2012 Jan 19;19(2):319–29. doi: 10.1007/s12350-011-9508-3.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e29609eaedd0db8c075de43aafa1451
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4397e0c38284ab753609ee120151e0d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d81861d520e95227e21fff80b6d21ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c2ff452fc366e817af3bdfabc4550f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f5176913a15d2e6bdbac18fa74d5b03
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c5046ddc8bb4a237dcd563cb8565792
date 2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s12350-011-9508-3
https://pubmed.ncbi.nlm.nih.gov/PMC3332362
https://pubmed.ncbi.nlm.nih.gov/22259009
isPartOf https://portal.issn.org/resource/ISSN/1532-6551
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20382
https://portal.issn.org/resource/ISSN/1071-3581
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
discusses http://id.nlm.nih.gov/mesh/M0495792
http://id.nlm.nih.gov/mesh/M0545364
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0018169
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219024
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10922

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129201965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129836330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127788218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128248166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128220647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129978672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129896981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127573844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128241576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129768020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128633517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129818107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129144708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128826430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129185848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 60.